466 related articles for article (PubMed ID: 26233944)
1. Antithrombotic strategy after bioprosthetic aortic valve replacement in patients in sinus rhythm: evaluation of guideline implementation.
van der Wall SJ; Umans VA; Schotten J; Keijzers M; Wolterbeek R; Jansen EK; Huisman MV; Vonk AB
Eur J Cardiothorac Surg; 2016 Apr; 49(4):1157-63. PubMed ID: 26233944
[TBL] [Abstract][Full Text] [Related]
2. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial.
Rafiq S; Steinbrüchel DA; Lilleør NB; Møller CH; Lund JT; Thiis JJ; Køber L; Olsen PS
Thromb Res; 2017 Feb; 150():104-110. PubMed ID: 27914653
[TBL] [Abstract][Full Text] [Related]
5. Early Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement in Elderly Patients: A Single-Center Experience.
Lee SI; Lee KS; Kim JB; Choo SJ; Chung CH; Lee JW; Jung SH
Ann Thorac Cardiovasc Surg; 2017 Jun; 23(3):128-134. PubMed ID: 28367855
[TBL] [Abstract][Full Text] [Related]
6. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
Goldsmith I; Lip GY; Mukundan S; Rosin MD
J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
[TBL] [Abstract][Full Text] [Related]
7. Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: a prospective multicenter study.
Chan V; Jamieson WR; Lam BK; Ruel M; Ling H; Fradet G; Mesana TG
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1053-8.e2. PubMed ID: 20546795
[TBL] [Abstract][Full Text] [Related]
8. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
[TBL] [Abstract][Full Text] [Related]
9. Is early antithrombotic therapy necessary after tissue mitral valve replacement?
Colli A; D'Amico R; Mestres CA; Pomar JL; Cámara ML; Ruyra X; Mulet J
J Heart Valve Dis; 2010 Jul; 19(4):405-11. PubMed ID: 20845885
[TBL] [Abstract][Full Text] [Related]
10. Association Between Antithrombotic Medication Use After Bioprosthetic Aortic Valve Replacement and Outcomes in the Veterans Health Administration System.
Bravata DM; Coffing JM; Kansagara D; Myers J; Murphy L; Homoya BJ; Perkins AJ; Snow K; Quin JA; Zhang Y; Myers LJ
JAMA Surg; 2019 Feb; 154(2):e184679. PubMed ID: 30586138
[TBL] [Abstract][Full Text] [Related]
11. Nonusefulness of Antithrombotic Therapy After Surgical Bioprosthetic Aortic Valve Replacement.
Gryaznov AA; Saeyeldin A; Abdelbaky M; Zafar MA; Tanweer M; Papanikolaou D; Imran M; Li Y; Ziganshin BA; Elefteriades JA
Am J Cardiol; 2020 Aug; 129():71-78. PubMed ID: 32605717
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Salem DN; Stein PD; Al-Ahmad A; Bussey HI; Horstkotte D; Miller N; Pauker SG
Chest; 2004 Sep; 126(3 Suppl):457S-482S. PubMed ID: 15383481
[TBL] [Abstract][Full Text] [Related]
13. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.
Aramendi JI; Mestres CA; Martinez-León J; Campos V; Muñoz G; Navas C
Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326
[TBL] [Abstract][Full Text] [Related]
14. High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Heras M; Chesebro JH; Fuster V; Penny WJ; Grill DE; Bailey KR; Danielson GK; Orszulak TA; Pluth JR; Puga FJ
J Am Coll Cardiol; 1995 Apr; 25(5):1111-9. PubMed ID: 7897124
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the antithrombotic strategy in low thrombotic risk patients who underwent aortic valve replacement with a bioprosthesis].
Aceves-Velázquez E; Vieyra-Herrera G; Rodríguez-Chávez L; Herrera-Alarcón V
Arch Cardiol Mex; 2018 Dec; 88(5):339-346. PubMed ID: 28720315
[TBL] [Abstract][Full Text] [Related]
16. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?
Sundt TM; Zehr KJ; Dearani JA; Daly RC; Mullany CJ; McGregor CG; Puga FJ; Orszulak TA; Schaff HV
J Thorac Cardiovasc Surg; 2005 May; 129(5):1024-31. PubMed ID: 15867776
[TBL] [Abstract][Full Text] [Related]
17. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study.
Albertal J; Sutton M; Pereyra D; Segura EV; Aramburu DF; Lardani H; Diaz R
J Heart Valve Dis; 1993 May; 2(3):302-7. PubMed ID: 8269123
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Whitlock RP; Sun JC; Fremes SE; Rubens FD; Teoh KH
Chest; 2012 Feb; 141(2 Suppl):e576S-e600S. PubMed ID: 22315272
[TBL] [Abstract][Full Text] [Related]
19. Comparison of apixaban versus aspirin for the prevention of latent bioprosthetic aortic valve thrombosis: study protocol for a prospective randomized trial.
Kopjar T; Gasparovic H; Paar MH; Lovric D; Cerina P; Tokic T; Milicic D
Trials; 2024 May; 25(1):324. PubMed ID: 38755709
[TBL] [Abstract][Full Text] [Related]
20. Impact of aspirin use in the incidence of thromboembolic events after bioprosthesis replacement in patients with rheumatic disease.
Durães AR; Durães MA; Correia LC; Fernandes AM; Aras Junior R
Rev Bras Cir Cardiovasc; 2013; 28(3):347-52. PubMed ID: 24343684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
